JMI LABS IS NOW PART OF LEARN MORE

Activity and Spectrum Evaluation of Dalbavancin, A Novel “Glycopeptide” Class Antimicrobial, presented at 41st annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December, 2001, Chicago, Illinois

View publication